![エクリズマブを使用している難治性全身型重症筋無力症患者でCOVID-19関連肺炎を罹患するも重症化しなかった1例](https://advpub.neurology-jp.org/wordpress/wp-content/uploads/2024/01/2cn1922f2.jpg)
Eculizumab led to beneficial clinical course in a patient with generalized myasthenia gravis who developed COVID 19-associated pneumonia
2024/01/27